What are the key biochemistry parameters to differentiate between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) in patients with suspected hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Biochemical Parameters to Differentiate DKA from HHS

The key biochemical parameters that distinguish DKA from HHS are: plasma glucose (DKA typically >250 mg/dL vs HHS ≥600 mg/dL), arterial pH (DKA <7.30 vs HHS >7.30), serum bicarbonate (DKA <18 mEq/L vs HHS >15 mEq/L), ketone presence (DKA strongly positive vs HHS small/trace), and effective serum osmolality (DKA variable vs HHS ≥320 mOsm/kg). 1

Primary Distinguishing Parameters

Plasma Glucose

  • DKA: Typically >250 mg/dL, though can present with euglycemia (especially with SGLT2 inhibitor use) 1, 2
  • HHS: ≥600 mg/dL, representing much more severe hyperglycemia 1

Arterial pH

  • DKA severity stratification 1, 2:
    • Mild: pH 7.25–7.30
    • Moderate: pH 7.00–7.24
    • Severe: pH <7.00
  • HHS: pH >7.30 (minimal to no acidosis) 1

Serum Bicarbonate

  • DKA severity stratification 1, 2:
    • Mild: 15–18 mEq/L
    • Moderate: 10 to <15 mEq/L
    • Severe: <10 mEq/L
  • HHS: >15 mEq/L 1

Ketone Bodies

  • DKA: Strongly positive serum and urine ketones 1
    • Critical point: β-hydroxybutyrate (β-OHB) measurement in blood is the preferred diagnostic method, as it is the predominant ketone in DKA 2
    • Nitroprusside-based tests (urine dipsticks, serum tablets) only detect acetoacetate and acetone, NOT β-OHB, and can be misleading during treatment 2
  • HHS: Small or trace ketones 1

Effective Serum Osmolality

  • DKA: Variable, not a defining feature 1
  • HHS: ≥320 mOsm/kg (calculated as: 2[measured Na (mEq/L)] + glucose (mg/dL)/18) 1

Anion Gap

  • DKA severity stratification 1, 3:
    • Mild: >10 mEq/L
    • Moderate/Severe: >12 mEq/L
    • Calculated as: (Na) - (Cl + HCO₃) (mEq/L) 1
  • HHS: Variable, may be elevated but less prominent than in DKA 1

Mental Status Correlation

Mental status changes correlate with severity 1:

  • DKA:
    • Mild: Alert
    • Moderate: Alert/drowsy
    • Severe: Stupor/coma
  • HHS: Typically stupor/coma due to severe hyperosmolality 1

Essential Initial Laboratory Workup

When differentiating these conditions, obtain 1, 2:

  • Plasma glucose
  • Arterial blood gas (pH, bicarbonate) or venous pH
  • Serum electrolytes with calculated anion gap
  • Blood urea nitrogen/creatinine
  • Serum β-hydroxybutyrate (preferred) or serum/urine ketones
  • Serum osmolality
  • Complete blood count with differential
  • Urinalysis
  • Electrocardiogram

Critical Differential Diagnosis Pitfall

Do not confuse DKA with alcoholic ketoacidosis (AKA), which presents with 1, 4:

  • Normal to mildly elevated glucose (rarely >250 mg/dL) or even hypoglycemia
  • Profound acidosis possible
  • Clinical history of alcohol use distinguishes it from DKA

Overlapping Presentations

Important caveat: Features of both disorders can coexist in the same patient, with varying degrees of ketoacidosis and hyperosmolality 5, 6. Both conditions share the common pathophysiology of insulinopenia and severe hyperglycemia, differing primarily in the magnitude of dehydration and degree of ketoacidosis 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Ketoacidosis Diagnostic Criteria and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Differentiating Alcoholic Ketoacidosis from Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic ketoacidosis and hyperosmolar hyperglycemic state.

Medizinische Klinik (Munich, Germany : 1983), 2006

Related Questions

What is the difference between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS)?
What will the patient's osmolality most likely be if they are in diabetic ketoacidosis (DKA) with hyperglycemia?
What is the appropriate insulin dose for a 112 kg patient with hyperglycemia (glucose 297) in the Emergency Department (ED)?
What are the key differences in lab findings and management between Hyperosmolar Hyperglycemic State (HHS) and Diabetic Ketoacidosis (DKA)?
What are the treatment differences between Hyperosmolar Hyperglycemic State (HHS) and Diabetic Ketoacidosis (DKA)?
What is the percentage reduction in urine protein-to-creatinine ratio (UPCR) in patients with IgA nephropathy treated with Sodium-Glucose Linked Transporter 2 (SGLT2) inhibitors, such as empagliflozin (Empagliflozin) or canagliflozin (Canagliflozin), over what period of time, and does the presence of Renin-Angiotensin System (RAS) inhibitors affect this outcome?
What is the initial management approach for a patient presenting with pneumonia, considering factors such as age, medical history, and severity of symptoms?
What are the implications of taking 7.5mg of letrozole (Femara) for 5 days from cycle day 3 to cycle day 7?
What is included in an Independent Medical Opinion (IMO) patient examination for a patient with a complex or chronic condition, such as a neurological disorder, cancer, or musculoskeletal condition?
What is the recommended treatment for an adult patient with trichomoniasis, a history of Human Papillomavirus (HPV) infection or Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), and at high risk for other sexually transmitted infections?
How does a history of prostate cancer affect ejaculation in a male patient over 50?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.